Clinical Trials
6 trialsNCT04892173 2026-06-05
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Johnson & Johnson Enterprise Innovation Inc.
Phase 3 Recruiting
NCT06064877 2026-04-09
FIERCE-HN
AVEO Pharmaceuticals, Inc.
Phase 3 Recruiting
NCT06908304 2026-01-12
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Maia Biotechnology
Phase 3 Recruiting
NCT05333523 2025-11-24
PRIMO
Radboud University Medical Center
Phase 3 Recruiting
NCT05955924 2025-02-21
SPRINTR
Women's College Hospital
Phase 3 Recruiting
NCT04747054 2024-10-26
PembroMetaRT
UNICANCER
Phase 3 Recruiting